Cardiovascular Systems - About the company
Cardiovascular Systems is an acquired company based in Saint Paul (United States), founded in 1989. It operates as a Developer of devices for treating peripheral and coronary vascular disease. Cardiovascular Systems has raised $121M in funding, with last known valuation of $*****. The company has 126 active competitors, including 35 funded and 34 that have exited. Its top competitors include companies like SMT, Aortyx and Thrombolex.
Company Details
Developer of devices for treating peripheral and coronary vascular disease. The products include Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart.
- Website
- csi360.com
- Registered Address
- 1225 Old Highway 8 NW St. Paul, MN 55112
Key Metrics
Founded Year
1989
Location
Saint Paul, United States
Stage
Acquired
Total Funding
$121M in 10 rounds
Latest Funding Round
Last Known Valuation
$***** as on Feb 08, 2023
Investors
Ranked
8th among 126 active competitors
Annual Revenue
$100M - $500M as on Jun 30, 2022
Employee Count
264 as on Jul 31, 2026
Investment & Acquisitions
Exit Details
Acquired by Abbott (Feb 08, 2023)
Legal entities associated with Cardiovascular Systems
Cardiovascular Systems is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Cardiovascular Systems, Inc. CIN: 411698056 , United States, Active | Dec 05, 2000 | - | 741 (As on Dec 31, 2022) | - |
CARDIOVASCULAR SYSTEMS INC CIN: 1180145 , United States, Active | Dec 05, 2000 | $100M - $500M (As on Jun 30, 2022) | - | - |
Cardiovascular Systems's acquisition details
Cardiovascular Systems got acquired by Abbott on Feb 08, 2023.
Click here to take a look at Cardiovascular Systems's acquisition in detail
Sign up to download Cardiovascular Systems' company profile
Cardiovascular Systems's funding and investors
Cardiovascular Systems has raised a total funding of $121M over 10 rounds. Its first funding round was on Aug 14, 2002. Cardiovascular Systems has 8 institutional investors.
Here is the list of recent funding rounds of Cardiovascular Systems:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 12, 2013 | 6679190 | Post IPO | 9116238 | 9102628 | 6771094 | 9728660 |
May 23, 2011 | 5423706 | Post IPO | 9500204 | 9366258 | 3499611 | 3151964 |
Dec 13, 2010 | 3417716 | Post IPO | 9872358 | 3488723 | 6306490 | 1554781 |
Access funding benchmarks and valuations. Sign up today!View details of Cardiovascular Systems's funding rounds and investors
Cardiovascular Systems' founders and board of directors
Founder? Claim ProfileCardiovascular Systems' employee count trend
Cardiovascular Systems has 264 employees as of Jul 26. Here is Cardiovascular Systems's employee count trend over the years:
Uncover Cardiovascular Systems' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cardiovascular Systems's Competitors and alternates
Top competitors of Cardiovascular Systems include SMT, Aortyx and Thrombolex. Here is the list of Top 10 competitors of Cardiovascular Systems, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of minimally invasive cardiovascular devices including coronary and structural heart | $93.5M | 71/100 | ||
2nd | Developer of smart devices for aortic diseases | $15.8M | 54/100 | ||
3rd | Thrombolex 2016, Doylestown (United States), Series A | Developer of endovascular catheters for acute venous thromboembolic conditions | $67.8M | 54/100 | |
4th | Medyria 2012, Winterthur (Switzerland), Series B | Developer of technology for endovascular catheter navigation and sensing | $12.3M | 53/100 | |
5th | Terumo Medical 1921, Shibuya (Japan), Funding Raised | Provider of a portfolio of medical devices for interventional cardiology | - | 52/100 | |
6th | Vascular Solutions 1997, Minneapolis (United States), Acquired | Products for vascular diagnostics and interventional procedures | $12M | 52/100 | |
7th | Experts in regenerative medicine | $5.44M | 51/100 | ||
8th | Cardiovascular Systems 1989, Saint Paul (United States), Acquired | Developer of devices for treating peripheral and coronary vascular disease | $121M | 50/100 | |
9th |  Sonovascular 2017, Chapel Hill (United States), Series A | eveloper of a medical device to treat arterial and venous diseases | $6M | 50/100 | |
10th | Spectranetics GSM 1984, Colorado Springs (United States), Acquired | Healthcare technology leader improving health through meaningful innovation | - | 50/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cardiovascular Systems's competitors? Click here to see the top ones
Cardiovascular Systems's Investments and acquisitions
Cardiovascular Systems has a total of 1 investment in CarePICS. Cardiovascular Systems has not made any acquisitions as of now.Reports related to Cardiovascular Systems
Here is the latest report on Cardiovascular Systems's geography:
News related to Cardiovascular Systems
Filter this list•
ClinChoice acquires CSI, expanding global footprint into Southeast AsiaBioSpectrum Asia•Jan 12, 2024•ClinChoice, CSI Medical Research, Cardiovascular Systems
•
ECLIPSE Clinical Trial Enrollment CompletedMedical Product Outsourcing•May 25, 2023•Cardiovascular Systems
•
Abbott completes $890M acquisition of Cardiovascular SystemsMassDevice•Apr 28, 2023•Cardiovascular Systems, Abbott
•
The M&A Class Action Firm Continues its Investigation of the Merger – ANGN, FOCS, UNVR, CSIIGlobeNewswire•Apr 13, 2023•Monteverde, Focus Financial Partners, CD&R, Angion Biomedica and 5 others
•
The M&A Class Action Firm Continues its Investigation of the Merger – NUVA, CSII, ANGN, AGFSGlobeNewswire•Apr 06, 2023•Monteverde, NuVasive, Cardiovascular Systems, Angion Biomedica and 1 other
•
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical TrialBusiness Wire•Apr 04, 2023•Cardiovascular Systems
•
The M&A Class Action Firm Continues its Investigation of the Merger – ANGN, CSII, AGFS, NUVAGlobeNewswire•Mar 30, 2023•Monteverde, Angion Biomedica, Elicio, Cardiovascular Systems and 5 others
•
The M&A Class Action Firm Continues its Investigation of the Merger – NUVA, ANGN, AGFS, CSIIGlobeNewswire•Mar 23, 2023•NuVasive, Angion Biomedica, AgroFresh, Cardiovascular Systems and 1 other
•
First Patient Enrolled in Japan for Cardiovascular Systems' Kaizen Clinical StudyMedical Product Outsourcing•Mar 16, 2023•Cardiovascular Systems
•
Kahn Swick & Foti, LLC Investigates AgroFresh Solutions, Inc. - AGFSBusiness Wire•Mar 14, 2023•Kahn Swick & Foti, AgroFresh, Paine Schwartz Partners, NuVasive and 2 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cardiovascular Systems
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company
